Showing 561 - 580 results of 67,668 for search '(( 50 ((((a decrease) OR (nn decrease))) OR (we decrease)) ) OR ( 05 0 decrease ))', query time: 0.91s Refine Results
  1. 561
  2. 562

    Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography by O. Stivalet (6890189)

    Published 2019
    “…In the subset of patients with an ABI >0.91, cut-off values of post-exercise ABI decrease (AUC = 0.67[0.53–0.78]), and DROP (AUC = 0.67[0.53–0.78]) were ≥18.5%, and ≤-15mmHg respectively (p<0.05).…”
  3. 563
  4. 564
  5. 565
  6. 566
  7. 567
  8. 568
  9. 569
  10. 570

    Factors affecting the biology of <i>Pachycrepoideus vindemmiae</i> (Hymenoptera: Pteromalidae), a parasitoid of spotted-wing drosophila (<i>Drosophila suzukii</i>) by Cherre S. Bezerra Da Silva (7026926)

    Published 2019
    “…Based on survival and host-killing capacity, we conclude that <i>P</i>. <i>vindemmiae</i> has a tremendous biocontrol potential against SWD. …”
  11. 571

    Presentation_1_Airway macrophages display decreased expression of receptors mediating and regulating scavenging in early cystic fibrosis lung disease.pdf by Lisa J. M. Slimmen (16464600)

    Published 2023
    “…The effect of age and neutrophilic inflammation, among other variables, on marker expression was assessed with a multivariate linear regression model.</p>Results<p>AM expression of scavenger receptor CD163 decreased with age (p = 0.016) and was negatively correlated with BALF %neutrophils (r = -0.34, p = 0.016). …”
  12. 572
  13. 573
  14. 574
  15. 575
  16. 576
  17. 577

    Data_Sheet_1_Combination of 0.05% Azelastine and 0.1% Tacrolimus Eye Drops in Children With Vernal Keratoconjunctivitis: A Prospective Study.PDF by Minjie Chen (561735)

    Published 2021
    “…<p>Aims: To compare the efficacy of the combination of 0. 05% azelastine and 0.1% tacrolimus eye drops with 0.1% tacrolimus monotherapy in pediatric patients with vernal keratoconjunctivitis (VKC).…”
  18. 578

    <i>In vitro</i> activity of aryl-thiazole derivatives against <i>Schistosoma mansoni</i> schistosomula and adult worms by Adriana S. A. Pereira (5900249)

    Published 2019
    “…After <i>in vitro</i> treatment for five days with 6.25 μM NJ05 or NJ07 separately, we observed a decrease of 30% in schistosomula viability, whilst treatment with NJ05+NJ07 lead to a reduction of 75% in viability measured by ATP quantitation and propidium iodide labeling. …”
  19. 579
  20. 580